• 6811 Citations
  • 43 Scopus h-Index
1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1988 2019

Filter
Article
2019

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis

Iqbal, M., Reljic, T., Ayala, E., Sher, T., Murthy, H., Roy, V., Foran, J., Tun, H., Kumar, A. & Kharfan-Dabaja, M. A., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Cutaneous T-Cell Lymphoma
Cell Transplantation
Meta-Analysis
Confidence Intervals
Recurrence
1 Citation (Scopus)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., Kaufman, J. L., Berg, D., Liao, E., Rajkumar, S. V. & Richardson, P. G., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Maintenance
Stem Cell Transplantation
Disease-Free Survival

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Monoclonal Antibodies
Premedication
Clinical Trials
Drug Utilization

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Survival Rate
Hispanic Americans
Epidemiology

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
Second Primary Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Survivors
Incidence
Survival Rate
2018
1 Citation (Scopus)

Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience

Dholaria, B. R., Hammond, W. A., Roy, V., Sher, T., Vishnu, P., Soyano, A., Finn, L. E. & Tun, H. W., Mar 23 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Lymphoma
Transplants
9 Citations (Scopus)
Primary Myelofibrosis
Hematopoietic Stem Cells
Karyotype
Transplants
Survival
7 Citations (Scopus)

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

Jain, T., Kunze, K. L., Temkit, M., Partain, D. K., Patnaik, M. M., Slack, J. L., Khera, N. D., Hogan, W., Roy, V., Noel, P., Leis, J. F., Sproat, L., Fauble, V., Mesa, R. A. & Palmer, J., May 24 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-8 8 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Hematopoietic Stem Cell Transplantation
Melphalan
Busulfan
Chimerism

Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions

Hefazi, M., Langer, K. J., Khera, N. D., Adamski, J., Roy, V., Winters, J. L., Gastineau, D. A., Jacob, E. K., Kreuter, J. D., Gandhi, M. J., Hogan, W., Litzow, M. R., Hashmi, S. K., Yadav, H., Iyer, V. N., Scott, J. P., Wylam, M., Cartin-Ceba, R. & Patnaik, M. M., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Photopheresis
Bronchiolitis Obliterans
Transplants
Lung
Survival

Impact of good and poor mobilizers on hematopoietic progenitor cell collection efficiency and product quality

Azzouqa, A. G. M., Jouni, K., Roy, V. & Zubair, A., Jan 1 2018, (Accepted/In press) In : Journal of Clinical Apheresis.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Granulocyte Colony-Stimulating Factor
Leukapheresis
Blood Component Removal
Autografts

Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant

Torres, M. E., Hashmi, S. K., Stevens, M. A., Tan, A. D., Callahan, V., Sloan, J. A., Hogan, W., Litzow, M. R., Roy, V., Foran, J. M. & Colon-Otero, G., Jan 1 2018, (Accepted/In press) In : Hematology/ Oncology and Stem Cell Therapy.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Caregivers
Quality of Life
Transplants
Multivariate Analysis

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S., Frank, R. D., Sharma, M., Roy, V., Ames, S., Rummans, T., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan Khan, A. A. & Ailawadhi, S., May 22 2018, In : Blood advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

Patient Acceptance of Health Care
Multiple Myeloma
Health Care Costs
Psychiatry
Comorbidity
24 Citations (Scopus)

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

V212 Protocol 001 Trial Team, May 26 2018, In : The Lancet. 391, 10135, p. 2116-2127 12 p.

Research output: Contribution to journalArticle

Herpes Zoster Vaccine
Chickenpox Vaccine
Inactivated Vaccines
Stem Cells
Vaccines

Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma

Ailawadhi, S., Dholaria, B. R., Khurana, S., Sher, T., Alegria, V., Paulus, A., Ailawadhi, M., Mehta, A., Chanan Khan, A. A. & Roy, V., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Multiple Myeloma
8 Citations (Scopus)

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Multiple Myeloma
Dexamethasone
Appointments and Schedules
Therapeutics
1 Citation (Scopus)

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Paulus, A., Manna, A., Akhtar, S., Paulus, S. M., Sharma, M., Coignet, M. V., Jiang, L., Roy, V., Witzig, T. E., Ansell, S. M., Allan, J., Furman, R., Aulakh, S., Manochakian, R., Ailawadhi, S., Chanan Khan, A. A. & Sher, T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytophagocytosis
Antibodies
B-Lymphocytes
Cell Death
8 Citations (Scopus)

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

Ailawadhi, S., Frank, R. D., Sharma, M., Menghani, R., Temkit, M., Paulus, S., Khera, N. D., Hashmi, S., Advani, P., Swaika, A., Paulus, A., Aslam, N., Sher, T., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Costs and Cost Analysis
Survival
Hispanic Americans
13 Citations (Scopus)

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Gonsalves, W., Buadi, F. K., Ailawadhi, S., Bergsagel, P. L., Chanan Khan, A. A., Dingli, D. M., Dispenzieri, A., Fonseca, R., Hayman, S. R., Kapoor, P., Kourelis, T., Lacy, M., Larsen, J. T., Muchtar, E., Reeder, C. B., Sher, T., Stewart, A. K., Warsame, R., Go, R. S., Kyle, R. A. & 14 others, Leung, N., Lin, Y., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Fonder, A. L., Hwa, Y. L., Hobbs, M. A., Mayo, A. A., Hogan, W., Rajkumar, S. V., Kumar, S. K., Gertz, M. & Roy, V., Jul 9 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-15 15 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Stem Cells
Transplants
Therapeutics
2017
43 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
23 Citations (Scopus)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S. K., Gertz, M., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D. M., Go, R. S., Lin, Y., Gonsalves, W., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Physical vapor deposition
10 Citations (Scopus)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-medicare analysis

Ailawadhi, S., Frank, R. D., Advani, P., Swaika, A., Temkit, M., Menghani, R., Sharma, M., Meghji, Z., Paulus, S., Khera, N. D., Hashmi, S. K., Paulus, A., Kakar, T. S., Hodge, D. O., Colibaseanu, D. T., Vizzini, M. R., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Stem Cells
Thalidomide
Transplants
3 Citations (Scopus)

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Dholaria, B., Patel, R. J., Sluzevich, J. C., Ailawadhi, S. & Roy, V., Sep 6 2017, (Accepted/In press) In : Annals of Hematology. p. 1-2 2 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Transplants
Subcutaneous panniculitis-like T-cell lymphoma
2016
15 Citations (Scopus)

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

Paulus, A., Akhtar, S., Caulfield, T., Samuel, K., Yousaf, H., Bashir, Y., Paulus, S. M., Tran, D., Hudec, R., Cogen, D., Jiang, J., Edenfield, B., Novak, A. J., Ansell, S. M., Witzig, T. E., Martin, P., Coleman, M., Roy, V., Ailawadhi, S., Chitta, K. & 2 others, Linder, S. & Chanan Khan, A. A., Nov 4 2016, In : Blood Cancer Journal. 6, 11, e492.

Research output: Contribution to journalArticle

Ubiquitin-Specific Proteases
Waldenstrom Macroglobulinemia
Hydrolases
Ubiquitin
Isoenzymes
8 Citations (Scopus)

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., Foran, J. M., Colon-Otero, G. & Chanan Khan, A. A., Feb 15 2016, In : Cancer. 122, 4, p. 618-625 8 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Multiple Myeloma
Registries
Neoplasms
Survival
28 Citations (Scopus)

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., LaPlant, B. R., Reeder, C. B., Roy, V., Halvorson, A. E., Buadi, F., Gertz, M., Bergsagel, P. L., Dispenzieri, A., Thompson, M. A., Crawley, J., Kapoor, P., Mikhael, J. R., Stewart, A. K., Hayman, S. R., Hwa, Y. L., Gonsalves, W., Witzig, T. E., Ailawadhi, S., Dingli, D. M. & 5 others, Go, R. S., Lin, Y., Rivera, C. E., Rajkumar, S. V. & Lacy, M., Nov 17 2016, In : Blood. 128, 20, p. 2415-2422 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Proteasome Inhibitors
4 Citations (Scopus)

Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum

Barba, P., Burns, L. J., Litzow, M. R., Juckett, M. B., Komanduri, K. V., Lee, S. J., Devlin, S. M., Costa, L. J., Khan, S., King, A., Klein, A., Krishnan, A., Malone, A., Mir, M., Moravec, C., Selby, G., Roy, V., Cochran, M., Stricherz, M. K., Westmoreland, M. D. & 2 others, Perales, M. A. & Wood, W. A., Mar 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 3, p. 564-570 7 p.

Research output: Contribution to journalArticle

Cell Transplantation
Transplantation
Bone Marrow
Learning
Delivery of Health Care
2015
9 Citations (Scopus)

Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma

Kumar, S. K., Krishnan, A., Laplant, B., Laumann, K., Roy, V., Zimmerman, T., Gertz, M., Buadi, F. K., Stockerl Goldstein, K., Birgin, A., Fiala, M., Duarte, L., Maharaj, M., Levy, J. & Vij, R., Dec 1 2015, In : American Journal of Hematology. 90, 12, p. 1106-1110 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Maximum Tolerated Dose
Bendamustine Hydrochloride
lenalidomide
1 Citation (Scopus)

Correction of factor XI deficiency by liver transplantation

Gupta, E., Finn, L., Johns, G., Pruthi, R. K. & Roy, V., 2015, In : Blood Coagulation and Fibrinolysis. 26, 8, p. 961-963 3 p.

Research output: Contribution to journalArticle

Factor XI Deficiency
Factor XI
Liver Transplantation
Liver
Transplants
86 Citations (Scopus)

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Mayo Phase Consortium, Jan 15 2015, In : Blood. 125, 3, p. 443-448 6 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinases
Multiple Myeloma
CDC2 Protein Kinase
Proteasome Inhibitors
Stabilization
4 Citations (Scopus)

Dual roles of autologous CD8+ T cells in hematopoietic progenitor cell mobilization and engraftment

Russell, A., Malik, S., Litzow, M. R., Gastineau, D., Roy, V. & Zubair, A., Jul 1 2015, In : Transfusion. 55, 7, p. 1758-1765 8 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
T-Lymphocytes
Chemotaxis
Neutrophils
Chemokine CXCL12
32 Citations (Scopus)

Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma

Vij, R., Kumar, S. K., Zhang, M. J., Zhong, X., Huang, J., Dispenzieri, A., Abidi, M. H., Bird, J. M., Freytes, C. O., Gale, R. P., Kindwall-Keller, T. L., Kyle, R. A., Landsburg, D. J., Lazarus, H. M., Munker, R., Roy, V., Sharma, M., Vogl, D. T., Wirk, B. & Hari, P. N., Feb 1 2015, In : Biology of Blood and Marrow Transplantation. 21, 2, p. 335-341 7 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Stem Cell Transplantation
Multiple Myeloma
Drug Therapy
Therapeutics
46 Citations (Scopus)

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., Laplant, B., Roy, V., Reeder, C. B., Lacy, M., Gertz, M., Laumann, K., Thompson, M. A., Witzig, T. E., Buadi, F. K., Rivera, C. E., Mikhael, J. R., Bergsagel, P. L., Kapoor, P., Hwa, L., Fonseca, R., Stewart, A. K., Chanan Khan, A. A., Rajkumar, S. V. & Dispenzieri, A., Aug 14 2015, In : Blood Cancer Journal. 4, e338.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Bortezomib
ixazomib
Proteasome Inhibitors
55 Citations (Scopus)

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Consensus
Expert Testimony
Therapeutics
2014
18 Citations (Scopus)

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

Paulus, A., Chitta, K., Akhtar, S., Personett, D., Miller, K. C., Thompson, K. J., Carr, J., Kumar, S. K., Roy, V., Ansell, S. M., Mikhael, J. R., Dispenzieri, A., Reeder, C. B., Rivera, C. E., Foran, J. M. & Chanan Khan, A. A., Feb 2014, In : British Journal of Haematology. 164, 3, p. 352-365 14 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Multiple Myeloma
Dexamethasone
Plasma Cells
Down-Regulation
52 Citations (Scopus)

Financial burden in recipients of allogeneic hematopoietic cell transplantation

Khera, N. D., Chang, Y. H., Hashmi, S., Slack, J. L., Beebe, T., Roy, V., Noel, P., Fauble, V., Sproat, L., Tilburt, J. C., Leis, J. F. & Mikhael, J. R., 2014, In : Biology of Blood and Marrow Transplantation. 20, 9, p. 1375-1381 7 p.

Research output: Contribution to journalArticle

Cell Transplantation
Health Behavior
Insurance
Bankruptcy
Insurance Coverage
38 Citations (Scopus)

Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Sharma, M., Zhang, M. J., Zhong, X., Abidi, M. H., Akpek, G., Bacher, U., Callander, N. S., Dispenzieri, A., Freytes, C. O., Fung, H. C., Gale, R. P., Gasparetto, C., Gibson, J., Holmberg, L. A., Kindwall-Keller, T. L., Klumpp, T. R., Krishnan, A. Y., Landau, H. J., Lazarus, H. M., Lonial, S. & 16 others, Maiolino, A., Marks, D. I., Mehta, P., Mikhael, J. R., Nishihori, T., Olsson, R., Ramanathan, M., Roy, V., Savani, B. N., Schouten, H. C., Scott, E., Tay, J., To, L. B., Vesole, D. H., Vogl, D. T. & Hari, P., Nov 1 2014, In : Biology of Blood and Marrow Transplantation. 20, 11, p. 1796-1803 8 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Cell Transplantation
Mortality
Disease-Free Survival
Multiple Myeloma
169 Citations (Scopus)

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: An open-label phase 1/2 study

Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., Kaufman, J. L., Berg, D., Liao, E., Di Bacco, A., Estevam, J., Gupta, N., Hui, A. M., Rajkumar, S. V. & Richardson, P. G., 2014, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Multiple Myeloma
Dexamethasone
Safety
Peripheral Nervous System Diseases
6 Citations (Scopus)

The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs

Paulus, A., Masood, A., Miller, K. C., Nazmul H. Khan, A. N. M., Akhtar, D., Advani, P., Foran, J. M., Rivera, C. E., Roy, V., Colon-Otero, G., Chitta, K. & Chanan Khan, A. A., 2014, In : British Journal of Haematology. 165, 1, p. 78-88 11 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Apoptosis
Pharmaceutical Preparations
Cell Death
Down-Regulation
2013

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

Larsen, J. T., Hogan, W., Micallef, I., Dispenzieri, A., Gertz, M., Inwards, D. J., Tun, H. W., Roy, V., Geyer, S. M., Allred, J. B., Wu, W., Ansell, S. M., Elliott, M. A., Tefferi, A., Porrata, L. F., Gastineau, D. A., Lacy, M. & Litzow, M. R., Aug 2013, In : Leukemia and Lymphoma. 54, 8, p. 1713-1718 6 p.

Research output: Contribution to journalArticle

Cladribine
Thiotepa
Antilymphocyte Serum
Hematologic Neoplasms
Rabbits
50 Citations (Scopus)

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

Witzig, T. E., Laumann, K. M., Lacy, M., Hayman, S. R., Dispenzieri, A., Kumar, S. K., Reeder, C. B., Roy, V., Lust, J. A., Gertz, M., Greipp, P. R., Hassoun, H., Mandrekar, S. J. & Rajkumar, S. V., Jan 2013, In : Leukemia. 27, 1, p. 220-225 6 p.

Research output: Contribution to journalArticle

zoledronic acid
Thalidomide
Multiple Myeloma
Confidence Intervals
11 Citations (Scopus)
docetaxel
Carboplatin
Breast Neoplasms
Neoadjuvant Therapy
Thrombocytopenia
88 Citations (Scopus)

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Copelan, E. A., Hamilton, B. K., Avalos, B., Ahn, K. W., Bolwell, B. J., Zhu, X., Aljurf, M., Van Besien, K., Bredeson, C., Cahn, J. Y., Costa, L. J., De Lima, M., Gale, R. P., Hale, G. A., Halter, J., Hamadani, M., Inamoto, Y., Kamble, R. T., Litzow, M. R., Loren, A. W. & 18 others, Marks, D. I., Olavarria, E., Roy, V., Sabloff, M., Savani, B. N., Seftel, M., Schouten, H. C., Ustun, C., Waller, E. K., Weisdorf, D. J., Wirk, B., Horowitz, M. M., Arora, M., Szer, J., Cortes, J., Kalaycio, M. E., Maziarz, R. T. & Saber, W., Dec 5 2013, In : Blood. 122, 24, p. 3863-3870 8 p.

Research output: Contribution to journalArticle

Busulfan
Acute Myeloid Leukemia
Cyclophosphamide
Leukemia
Confidence Intervals
257 Citations (Scopus)
Multiple Myeloma
Guidelines
Plasma Cell Neoplasms
Poisons
Therapeutics
59 Citations (Scopus)

Salvage Second Hematopoietic Cell Transplantation in Myeloma

Michaelis, L. C., Saad, A., Zhong, X., Le-Rademacher, J., Freytes, C. O., Marks, D. I., Lazarus, H. M., Bird, J. M., Holmberg, L., Kamble, R. T., Kumar, S. K., Lill, M., Meehan, K. R., Saber, W., Schriber, J., Tay, J., Vogl, D. T., Wirk, B., Savani, B. N., Gale, R. P. & 29 others, Vesole, D. H., Schiller, G. J., Abidi, M., Anderson, K. C., Nishihori, T., Kalaycio, M. E., Vose, J. M., Moreb, J. S., Drobyski, W., Munker, R., Roy, V., Ghobadi, A., Holland, H. K., Nath, R., To, L. B., Maiolino, A., Kassim, A. A., Giralt, S. A., Landau, H., Schouten, H. C., Maziarz, R. T., Michael, J., Kindwall-Keller, T., Stiff, P. J., Gibson, J., Lonial, S., Krishnan, A., Dispenzieri, A. & Hari, P., May 2013, In : Biology of Blood and Marrow Transplantation. 19, 5, p. 760-766 7 p.

Research output: Contribution to journalArticle

Cell Transplantation
Multiple Myeloma
Survival
Transplants
Recurrence
54 Citations (Scopus)

Smoldering multiple myeloma requiring treatment: Time for a new definition?

Dispenzieri, A., Stewart, A. K., Chanan Khan, A. A., Rajkumar, S. V., Kyle, R. A., Fonseca, R., Kapoor, P., Bergsagel, P. L., McCurdy, A., Gertz, M., Lacy, M., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Reeder, C., Roy, V., Buadi, F., Dingli, D. M., Hayman, S. R., Leung, N. & 3 others, Lin, Y., Mikhael, J. R. & Kumar, S. K., Dec 19 2013, In : Blood. 122, 26, p. 4172-4181 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone
Air cushion vehicles
Dexamethasone
Immunoglobulins
2012
83 Citations (Scopus)

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

Dispenzieri, A., Buadi, F., Laumann, K., LaPlant, B., Hayman, S. R., Kumar, S. K., Dingli, D. M., Zeldenrust, S. R., Mikhael, J. R., Hall, R., Rajkumar, S. V., Reeder, C., Fonseca, R., Bergsagel, P. L., Stewart, A. K., Roy, V., Witzig, T. E., Lust, J. A., Russell, S. J., Gertz, M. & 1 others, Lacy, M., Jun 7 2012, In : Blood. 119, 23, p. 5397-5404 8 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Natriuretic Peptides
Pharmaceutical Preparations
Dexamethasone
36 Citations (Scopus)

Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization

Vishnu, P., Roy, V., Paulsen, A. & Zubair, A., Jan 2012, In : Transfusion. 52, 1, p. 55-62 8 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Cost-Benefit Analysis
JM 3100
Blood Component Removal
Blood Cell Count
9 Citations (Scopus)

Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent

Jiang, L., Malik, S., Litzow, M. R., Gastineau, D., Micallef, I., Roy, V., Solberg, L. & Zubair, A., Mar 2012, In : Transfusion. 52, 3, p. 542-548 7 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Neutrophils
Blood Platelets
Cell Count
CD34 Antigens
11 Citations (Scopus)

Immunoglobulin D amyloidosis: A distinct entity

Gertz, M., Buadi, F. K., Hayman, S. R., Dingli, D. M., Dispenzieri, A., Greipp, P. R., Kumar, S. K., Lacy, M., Lust, J. A., Leung, N., Rajkumar, S. V., Russell, S. J., Zeldenrust, S. R., Mikhael, J. R., Roy, V. & Kyle, R. A., Jan 5 2012, In : Blood. 119, 1, p. 44-48 5 p.

Research output: Contribution to journalArticle

Immunoglobulin D
Amyloidosis
Proteins
Hospital Distribution Systems
Monoclonal Gammopathy of Undetermined Significance
81 Citations (Scopus)

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: Long-term results from a phase 2 trial

Kumar, S. K., Hayman, S. R., Buadi, F. K., Roy, V., Lacy, M., Gertz, M., Allred, J., Laumann, K. M., Bergsagel, P. L., Dingli, D. M., Mikhael, J. R., Reeder, C. B., Stewart, A. K., Zeldenrust, S. R., Greipp, P. R., Lust, J. A., Fonseca, R., Russell, S. J., Rajkumar, S. V. & Dispenzieri, A., May 24 2012, In : Blood. 119, 21, p. 4860-4867 8 p.

Research output: Contribution to journalArticle

Amyloidosis
Cyclophosphamide
Dexamethasone
Toxicity
Light